---
title: "Conference Brochure"
author: "Sankhya 2024"
date: "Saturday, August 3, 2024"
output:
  pdf_document:
    toc: yes
    toc_depth: '2'
  html_document:
    toc: yes
    toc_depth: 2
    number_sections: no
    theme: readable
    highlight: tango
    keep_tex: yes
    css: assets/css/styles.css
---

<style>
body {
text-align: justify}

.abstract-box {
  border: 1px solid #ddd;
  border-radius: 5px;
  padding: 15px;
  margin: 10px 0;
  background-color: #f9f9f9;
}
</style>

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo       = FALSE, 
                      warning    = FALSE, 
                      include    = TRUE, 
                      message    = FALSE, 
                      fig.height = 4, 
                      out.width  = "100%")
```

```{css}
.box {
    padding: 10px;
    display: none;
    margin-top: 10px;
}
```

```{r}
library(htmltools)

abstract_data <- readxl::read_excel("abstracts.xlsx")

id <- abstract_data$ID
title <- abstract_data$PropTitle2
lead <- abstract_data$Lead_Presenter
authors <- abstract_data$Authors
abstract <- abstract_data$Abstract
conclusion <- abstract_data$Conclusion
keywords <- paste(abstract_data$Keyword1, ",", abstract_data$Keyword2, ",", abstract_data$Keyword3)
```

```{js}
// jQuery functions to hide and show the div
$(document).ready(function () {
    $("select").change(function () {
        $(this).find("option:selected")
               .each(function () {
            var optionValue = $(this).attr("value");
            if (optionValue) {
                $(".box").not("." + optionValue).hide();
                $("." + optionValue).show();
            } else {
                $(".box").hide();
            }
        });
    }).change();
});
```

***

# Conference Overview

Sankhya 2024 conference emphasizes the use of statistical and quantitative sciences in drug discovery, development, life cycle management, as well as daily operations and business services. The 13th edition of this series is a collaborative effort between Development Advanced Quantitative Sciences (AQS), India, and Global Business Solutions (GBS), India.

The conference will feature scientific talks and poster presentations on a variety of topics, including case studies, regulatory guidelines, and business needs. The presenters will comprise associates from Novartis and other pharmaceutical companies.

Your participation in this event is greatly appreciated.

***

# The Keynote Speaker: Dr Arijit Nag, MD (Internal Medicine), DM (Clinical Hematology), MRCP (UK); Tata Medical Center, Kolkata

Dr. Arijit Nag is a Clinical Scientist in the Department of Clinical Hematology and Cellular Therapies at Tata Medical Center, Kolkata. As a dedicated hematologist with a keen interest in Leukemia biology, he specialises in treating patients with Acute Leukemia and performing stem cell transplantation. His work is driven by the goal of improving survival outcomes for patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia. Dr. Nag is committed to making innovative treatments more accessible and available to his patients, ensuring they receive the best possible care.

<!-- Twitter feed: @docarijit -->

<!-- LinkedIn profile: https://www.linkedin.com/in/arijit-nag-0135ba8a/ -->

<!-- Google scholar link: https://scholar.google.co.in/citations?user=dVeO-UoAAAAJ&hl=en -->

<!-- X (Twitter): [![X URL](https://img.shields.io/twitter/url/https/twitter.com/docarijit.svg?style=social&label=Follow%20%40docarijit)](https://x.com/docarijit) -->

<!-- LinkedIn: [![text](https://img.shields.io/badge/LinkedIn-0077B5?style=for-the-badge&logo=linkedin&logoColor=white)](https://www.linkedin.com/in/arijit-nag-0135ba8a/) -->

<!-- Google scholar: <a href="https://scholar.google.co.in/citations?user=dVeO-UoAAAAJ&hl=en"><img src="./assets/img/scholar.png" width="30"/></a> -->


[![X URL](https://img.shields.io/twitter/url/https/twitter.com/docarijit.svg?style=social&label=Follow%20%40docarijit)](https://x.com/docarijit) [![text](https://img.shields.io/badge/LinkedIn-0077B5?style=for-the-badge&logo=linkedin&logoColor=white)](https://www.linkedin.com/in/arijit-nag-0135ba8a/) <a href="https://scholar.google.co.in/citations?user=dVeO-UoAAAAJ&hl=en"><img src="./assets/img/scholar.png" width="30"/></a>



***

# Program Schedule and Abstracts {.tabset}

### Session 1 - 09:30 onwards

<details>
<summary>09:30 to 09:45 - Welcome and Inauguration</summary>
Welcome and Inauguration
</details>

<details>
<summary>09:45 to 10:40 - Keynote Address by Dr. Arijit Nag</summary>
**Title:** Harnessing the power of biostatistics in cancer medicine

**Speaker:** Dr Arijit Nag, Dr Arijit Nag, MD (Internal Medicine), DM (Clinical Hematology), MRCP (UK); Tata Medical Center, Kolkata 

**Abstract:** Biostatistics plays a crucial role in advancing cancer medicine by providing essential tools for designing studies, analyzing data, and interpreting results. Biostatistics is at the heart of cancer research, and we shall analyse its impact on clinical trials, epidemiological studies, and personalized medicine. By employing rigorous statistical techniques, researchers can identify risk factors, evaluate treatment efficacy, and optimize patient outcomes. 

Recent advancements, such as the application of machine learning and big data analytics, have further enhanced the capacity of biostatistics to address complex challenges in oncology. One such instance is the development of predictive models that guide treatment decisions and improve prognostic accuracy. Additionally, the use of bioinformatics in conjunction with biostatistics facilitates the integration of genomic data, enabling a more nuanced understanding of tumor behavior and patient heterogeneity. 

Collaborative efforts between biostatisticians and clinical researchers are essential for translating statistical findings into actionable insights. This partnership fosters the design of innovative trials, such as adaptive designs, which can respond dynamically to interim results, ultimately leading to more efficient drug development processes.

Harnessing the power of biostatistics in cancer medicine not only enhances the robustness of research findings but also paves the way for more personalised and effective therapeutic strategies. As the field continues to evolve, the synergy between biostatistics and cancer research will remain pivotal in shaping the future of oncology and improving patient care outcomes.
</details>

<details>
<summary>10:40 to 10:50 - Break</summary>
Break
</details>

### Session 2 - 10:50 onwards

<details>
<summary> 10:50 to 11:10 - `r title[38]` by Rajkumar Radhakrishnan (Novartis) </summary>
**Title:** `r title[38]`

**Author(s):** `r authors[38]`

**Abstract:** `r abstract[38]`

**Conclusions:** `r conclusion[38]`

**Keywords:** `r keywords[38]`
</details>

<details>
<summary> 11:10 to 11:30 - `r title[68]` by `r lead[68]` </summary>
**Title:** `r title[68]`

**Author(s):** `r authors[68]`

**Abstract:** `r abstract[68]`

**Conclusions:** `r conclusion[68]`

**Keywords:** `r keywords[68]`
</details>

<details>
<summary> 11:30 to 11:50 - `r title[69]` by `r lead[69]` </summary>
**Title:** `r title[69]`

**Author(s):** `r authors[69]`

**Abstract:** `r abstract[69]`

**Conclusions:** `r conclusion[69]`

**Keywords:** `r keywords[69]`
</details>

<details>
<summary> 11:50 to 12:10 - `r title[29]` by Rashidkhan Pathan (Novartis) </summary>
**Title:** `r title[29]`

**Author(s):** `r authors[29]`

**Abstract:** `r abstract[29]`

**Conclusions:** `r conclusion[29]`

**Keywords:** `r keywords[29]`
</details>

<details>
<summary> 12:10 to 12:30 - Q&A for Session 1.2 </summary>
Q&A for Session 1.2
</details>

<details>
<summary> 12:30 to 13:30 - Lunch Break </summary>
Lunch Break
</details>

### Session 3 - 13:30 onwards 

<details>
<summary> 13:30 to 13:50 - `r title[19]` by	Aquib Ansari (Novartis) </summary>
**Title:** `r title[19]`

**Author(s):** `r authors[19]`

**Abstract:** `r abstract[19]`

**Conclusions:** `r conclusion[19]`

**Keywords:** `r keywords[19]`
</details>

<details>
<summary> 13:50 to 14:10 - `r title[17]` by	Venugopala Rao Manneni (Novartis) </summary>
**Title:** `r title[17]`

**Author(s):** `r authors[17]`

**Abstract:** `r abstract[17]`

**Conclusions:** `r conclusion[17]`

**Keywords:** `r keywords[17]`
</details>

<details>
<summary> 14:10 to 14:30 - `r title[71]` by Sanchayita Sadhu (GSK) </summary>
**Title:** `r title[71]`

**Author(s):** `r authors[71]`

**Abstract:** `r abstract[71]`

**Conclusions:** `r conclusion[71]`

**Keywords:** `r keywords[71]`
</details>

<details>
<summary> 14:30 to 14:50 - `r title[73]` by Apoorva Sood (Novo Nordisk) </summary>
**Title:** `r title[73]`

**Author(s):** `r authors[73]`

**Abstract:** `r abstract[73]`

**Conclusions:** `r conclusion[73]`

**Keywords:** `r keywords[73]`
</details>

<details>
<summary> 14:50 to 15:10 - Q&A for Session 1.3 </summary>
Q&A for Session 1.3
</details>

<details>
<summary> 15:10 to 15:30 - High Tea </summary>
High Tea
</details>

### Session 4 - 15:30 onwards 

<details>
<summary> 15:30 to 15:50 - `r title[72]` by	Rupam Ranjan Pal (GSK) </summary>
**Title:** `r title[72]`

**Author(s):** `r authors[72]`

**Abstract:** `r abstract[72]`

**Conclusions:** `r conclusion[72]`

**Keywords:** `r keywords[72]`
</details>

<details>
<summary> 15:50 to 16:10 - `r title[4]` by Bijoy Kumar Dey (Novartis) </summary>
**Title:** `r title[4]`

**Author(s):** `r authors[4]`

**Abstract:** `r abstract[4]`

**Conclusions:** `r conclusion[4]`

**Keywords:** `r keywords[4]`
</details>

<details>
<summary> 16:10 to 16:20 - Q&A for Session 1.4 </summary>
Q&A for Session 1.4
</details>

<details>
<summary>16:20 to 16:40 Closing & Vote of Thanks</summary>
Closing & Vote of Thanks by Arghya Chattopadhyay
</details>

***

# Committee Information

## Sponsors
- Arghya Chattopadhyay, Biostatistics Site Head, Advanced Quantitative Sciences, Development India
- Praveen Dass, Head - Clinical Trial Operations, Global Business Solutions, India

## Advisor
- Priti Pandey, Director Biostatistics, Advanced Quantitative Sciences, Development India

## Organising Committee
- Anil Gaur
- Chaitali Pisal
- Gopi Madhav
- Kishan Bharadwaj
- Punjita
- Shaheen Islam
- Vijayasree Sabbineni
- Yogesh Chattar (Lead)

## Abstract Review Committee
- Kohinoor Dasgupta (Lead)
- Saikat Mukhopadhyay
- Sharon Varghese A
- Vipin N

***